These success, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assistance the thought of targeting ACKR3 as a novel solution to modulate the opioid process, which could open new therapeutic avenues for opioid-linked Diseases.A research research posted in Anesthesiology and D